The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Gut microbiota alterations are important in irritable bowel syndrome (IBS). The aim was to investigate the effect of fecal microbiota transplantation (FMT) on gut microbiota and the symptoms in patients with IBS. MATERIAL AND METHODS: The study included 13 IBS patients according to Rome III criteria and 13 healthy donors. Freshly donated feces were administered to the descending part of the duodenum via a gastroscope. Feces were collected from donors and patients before FMT, and from the patients at 1, 3 and 12 weeks and donors and patients at 20/28 weeks after FMT. Microbiota analysis was performed using GA-map Dysbiosis test (Genetic Analysis AS, Oslo, Norway). The patients completed the following questionnaires before and at the aforementioned weeks after FMT: IBS Symptom Questionnaire (IBS-SQ), IBS-Symptom Severity Scoring system (IBS-SSS), Short Form of Nepean Dyspepsia Index (SF-NDI), Bristol stool form scale, the Eysenck Personality Questionnaire-Neuroticism and Hospital Anxiety and Depression. RESULTS: Donors and IBS patients had significantly different bacterial strain signals before FMT (Ruminococcus gnavus, Actinobacteria and Bifidobacteria) that became non-significant after 3 weeks following FMT. The changes in gut microbiota were similar between donors and patients at 20/28 weeks after FMT. Thus, patients' microbiota profiles became more-or-less similar to donors. The scores of all the questionnaires were significantly improved at all time points following FMT. No reported adverse effects. CONCLUSIONS: FMT was associated with a change in gut microbiota and improvement in IBS symptoms and quality of life lasting for up to 28 weeks. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT03333291.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“but the majority found this to be transient (Xie et al. 2019 [45]; H. L. Huang et al. 2019 [46]; Mazzawi et al. 2018 [44]; Mizuno et al. 2017 [47]).”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as Mazzawi et al. 2018 [44]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Only Mazzawi et al. [92] and Kurokawa et al. [95] performed the FDR correction.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [92]
In the citing paper
“The long-term effects were less consistent, with three studies finding a return to baseline at week 12, week 20, and month 6 respectively [44–46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [46]
In the citing paper
“A significant decrease in EPQ-N-12 scores was seen at week 3, but this returned to baseline by week 20 [46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
FRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708
Symptomatic atherosclerosis is associated with an altered gut metagenome
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371
Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects
World Medical Association (WMA) (2009) · Jahrbuch für Wissenschaft und Ethik · doi:10.1515/9783110208856.233 · Cited by 1,087
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
(1958) · PubMed · Cited by 978
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835
Botega, N. J., Bio, M. R., Zomignani, M. A., Garcia Jr, C., & Pereira, W. A. B. (1995) · Revista de Saúde Pública · doi:10.1590/s0034-89101995000500004 · Cited by 826
Hungin, A. P. S., Whorwell, P. J., Tack, J., & Mearin, F. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01456.x · Cited by 781
Gastrointestinal Microflora Studies in Late‐Onset Autism
Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M., Bolte, E., McTeague, M., Sandler, R., Wexler, H., Marlowe, E. M., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341914 · Cited by 742
Brandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., & Surawicz, C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.60 · Cited by 672
Food-Related gastrointestinal symptoms in the irritable bowel syndrome
Simrén, M., Månsson, A., Langkilde, A. M., Svedlund, J., Abrahamsson, H., Bengtsson, U., & Björnsson, E. S. (2001) · Digestion · doi:10.1159/000051878 · Cited by 529
Fecal microbiota transplantation: in perspective
Gupta, S., Allen-Vercoe, E., & Petrof, E. O. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15607414 · Cited by 481
tana, C., umesaki, Y., imaoka, A., handa, T., kanazawa, M., & fukudo, S. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01427.x · Cited by 474
Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428
Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Borody, T. J., Warren, E. F., Leis, S., Surace, R., & Ashman, O. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200307000-00012 · Cited by 388
Monsbakken, K. W., Vandvik, P. O., & Farup, P. G. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602367 · Cited by 364
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
Kane, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00232-6 · Cited by 364
PROSPECTIVE DIAGNOSIS OF SPINA BIFIDA
Brock, D. J. H., Scrimgeour, J. B., Chard, T., Leek, A. E., Kitau, M. J., & Leighton, P. C. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91459-2 · Cited by 361
Jalanka-Tuovinen, J., Salojärvi, J., Salonen, A., Immonen, O., Garsed, K., Kelly, F. M., Zaitoun, A., Palva, A., Spiller, R. C., & de Vos, W. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305994 · Cited by 340
Fecal microbiota transplantation: past, present and future
Aroniadis, O. C., & Brandt, L. J. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a4b3e · Cited by 336
Treatment of ulcerative colitis by implantation of normal colonic flora
Bennet, J., & Brinkman, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91183-5 · Cited by 304
Casén, C., Vebø, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., Dzankovic, S., Frøyland, C., Nestestog, R., Engstrand, L., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13236 · Cited by 289
Menees, S. B., Maneerattannaporn, M., Kim, H. M., & Chey, W. D. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.355 · Cited by 283
Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01893.x · Cited by 256
Hustoft, T. N., Hausken, T., Ystad, S. O., Valeur, J., Brokstad, K., Hatlebakk, J. G., & Lied, G. A. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.12969 · Cited by 218
Self-citationRELAPSING CLOSTRIDIUM DIFFICILE ENTEROCOLITIS CURED BY RECTAL INFUSION OF HOMOLOGOUS FAECES
SCHWAN, A. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90753-5 · Cited by 196
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
Gearry, R., Skidmore, P., O'Brien, L., Wilkinson, T., & Nanayakkara, W. (2016) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s86798 · Cited by 191
JACKSON, J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90886-6 · Cited by 185
Development of functional gastrointestinal disorders after Giardia lambliainfection
Hanevik, K., Dizdar, V., Langeland, N., & Hausken, T. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-27 · Cited by 172
Self-citationBrandt, L. J. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.450 · Cited by 171
Saito, Y. A. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.011 · Cited by 164
Are adverse food reactions linked to irritable bowel syndrome?
Niec, A. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00412-2 · Cited by 158
Dysbiosis in gastrointestinal disorders
Chang, C., & Lin, H. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.001 · Cited by 158
Sisson, G., Ayis, S., Sherwood, R. A., & Bjarnason, I. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12787 · Cited by 147
Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
M.P. Bennet, S., Ohman, L., & Simren, M. (2015) · Gut and Liver · doi:10.5009/gnl14344 · Cited by 141
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115
Ghoshal, U. C., & Srivastava, D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2482 · Cited by 113
Is irritable bowel syndrome an organic disorder?
El‐Salhy, M., Gundersen, D., Gilja, O. H., Hatlebakk, J. G., & Hausken, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.384 · Cited by 106
Self-citationBotega, N. J., Bio, M. R., Zomignani, M. A., Garcia, C., & Pereira, W. A. (2015) · Americanae (AECID Library) · Cited by 106
Pinn, D. M., Aroniadis, O. C., & Brandt, L. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.295 · Cited by 94
Mathias, J. R., Clench, M. H., Reeves-Darby, V. G., Fox, L. M., Hsu, P. H., Roberts, P. H., Smith, L. L., & Stiglich, N. J. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02093778 · Cited by 78
MAZZAWI, T., HAUSKEN, T., GUNDERSEN, D., & EL-SALHY, M. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1565 · Cited by 75
Self-citationUnraveling the ties between irritable bowel syndrome and intestinal microbiota
Hong, S. N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2470 · Cited by 75
Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating
Holvoet, T., Joossens, M., Wang, J., Boelens, J., Verhasselt, B., Laukens, D., Vlierberghe, H. V., Hindryckx, P., Vos, M. D., Looze, D. A. D., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312513 · Cited by 68
Arslan, G., Lind, R. A., Ólafsson, S., Florvaag, E., & Berstad, A. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000026318.81635.3b · Cited by 66
Staley, C., Vaughn, B. P., Graiziger, C. T., Singroy, S., Hamilton, M. J., Yao, D., Chen, C., Khoruts, A., & Sadowsky, M. J. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1299310 · Cited by 53
Ishihara, S., Tada, Y., Fukuba, N., Oka, A., Kusunoki, R., Mishima, Y., Oshima, N., Moriyama, I., Yuki, T., Kawashima, K., et al. (2013) · Digestion · doi:10.1159/000350054 · Cited by 52
On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens
Grover, M., Camilleri, M., Smith, K., Linden, D. R., & Farrugia, G. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12304 · Cited by 48
Mazzawi, T. R. E., & El‐Salhy, M. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3096 · Cited by 27
Self-citationFäkaler Mikrobiom-Transfer bei therapierefraktärem Diarrhoe-betontem Reizdarmsyndrom
Zoller, V., Laguna, A. J., da Costa, O. P., Buch, T., Göke, B., & Storr, M. (2015) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0041-103798 · Cited by 17
Research works printed but not linked: 1
- V Zoller, 2015, Fecal microbiota transfer (FMT) in a patient with refractory irritable bowel syndrome, Deutsche medizinische Wochenschrift (1946), 140, 1232
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
D’Amato, A., Di Cesare Mannelli, L., Lucarini, E., Man, A. L., Le Gall, G., Branca, J. J. V., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00914-w · Cited by 269
“Not surprisingly, faecal microbiota transplant (FMT) is being investigated as a therapeutic option not only for GI-tract-related diseases [13], but also for CNS disorders [14, 15].”
BackgroundCurrent approaches in lipid-based nanocarriers for oral drug delivery
Plaza-Oliver, M., Santander-Ortega, M. J., & Lozano, M. V. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00908-7 · Cited by 249
Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review
Chinna Meyyappan, A., Forth, E., Wallace, C. J. K., & Milev, R. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02654-5 · Cited by 254
“Low Low Zhao 2019 [39] Low Low Low Low Low Kelly 2016 [34] Unclear Unclear Low Low Low Mizuno 2017 [44] Low High Participants and personnel not blinded.”
BackgroundWei, S., Bahl, M. I., Baunwall, S. M. D., Hvas, C. L., & Licht, T. R. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.00395-21 · Cited by 172
“(18, 19), and this was further lowered by repetitive FMT (17).”
Background
Metadata
- Authors
- Mazzawi, T., Lied, G. A., Sangnes, D. A., El-Salhy, M., Hov, J. R., Gilja, O. H., Hatlebakk, J. G., & Hausken, T.
- Affiliations
- Haukeland University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Mazzawi, Tarek
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-11-14
- Volume
- 13
- Issue
- 11
- Pages
- e0194904
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6235238
- OpenAlex
- W2900510600
- Cited by
- 92
- References
- 58
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 10 · 2023: 13 · 2022: 11 · 2021: 16 · 2020: 22 · 2019: 9 · 2018: 2
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Helse Vest Regionalt Helseføretak (911802)
- Norwegian Research Council (240787/F20)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- irritable bowel syndrome, fecal microbiota transplantation, gut microbiota composition, microbiota dynamics, dysbiosis, Ruminococcus gnavus, Bifidobacterium, quality of life, anxiety and depression
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adolescent, Adult, Aged, Feces, Female, Humans, Male, Middle Aged, Quality of Life, Irritable Bowel Syndrome, Young Adult, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.